Class C07J : STEROIDS
Subclass 53/00: Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11987600 | Contraceptive use of triterpenoids | Jun 18, 19 | May 21, 24 | The Regents of the University of California |
| 11667669 | Epoxy-(meth)acrylate monomers and polymers and methods of making and using the same | Aug 13, 19 | Jun 06, 23 | Rowan University; The United States of America as represented by the Secretary of the Army; |
| 11661437 | Steroid derivative regulators, method for preparing the same, and uses thereof | Jan 31, 19 | May 30, 23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Hansoh Biomedical Co., Ltd.; |
| 11312681 | Molecular host frameworks and methods of making and using same | Jun 07, 19 | Apr 26, 22 | New York University |
| 11084845 | C-3 and C-17 modified triterpenoids as HIV-1 inhibitors | Aug 07, 19 | Aug 10, 21 | ViiV HEALTHCARE UK (NO. 5) LIMITED |
| 10676418 | Method for producing microparticles from pressurized and heated starting material solution | Sep 05, 17 | Jun 09, 20 | M. Technique Co., Ltd |
| 10669305 | C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors | Oct 12, 16 | Jun 02, 20 | HETERO LABS LIMITED |
| 10576091 | Tomatidine, analogs thereof, compositions comprising same, and uses for same | Jun 08, 18 | Mar 03, 20 | The University of Iowa Research Foundation; The United States Government as Represented by the Department of Veterans Affairs; |
| 10570312 | Method for the separation of the isoprenic constituents of guayule | Jul 29, 16 | Feb 25, 20 | Versalis S.p.A. |
| 10550147 | Cyclopentanoperhydrophenanthrene framework compounds and preparation method therefor | Jan 08, 15 | Feb 04, 20 | SICHUAN JINGHUACHUANG BIOTECHNOLOGY CORPORATION |
| 10421774 | C-3 and C-17 modified triterpenoids as HIV-1 inhibitors | Feb 02, 17 | Sep 24, 19 | ViiV Healthcare UK (No. 5) Limited |
| 10202415 | Method of synthesizing of 3-oxolupenal nanoparticles | Oct 19, 17 | Feb 12, 19 | King Saud University |
| 10064873 | Compounds and compositions for treating HIV with derivatives of Betulin | Mar 21, 17 | Sep 04, 18 | GlaxoSmithKline LLC |
| 10022386 | Tomatidine, analogs thereof, compositions comprising same, and uses for same | Dec 22, 15 | Jul 17, 18 | The University of Iowa Research Foundation; The United States of America as represented by the Department of Veterans Affairs; |
| 10017535 | Amphiphilic compounds with neuroprotective properties | Aug 25, 15 | Jul 10, 18 | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.; FYZIOLOGICKY USTAV AV CR, v.v.i.; |
| 9969767 | Oxolupene derivatives | Nov 12, 15 | May 15, 18 | ViiV Healthcare UK (No. 5) Limited |
| 9969768 | Oleanolic acid methyl ester derivatives | Nov 16, 17 | May 15, 18 | King Saud University |
| 9913851 | Compositions and methods for increasing telomerase activity | Dec 10, 15 | Mar 13, 18 | TELOMERASE ACTIVATION SCIENCES, INC. |
| 9856204 | Methods for inhibiting muscle atrophy | May 19, 11 | Jan 02, 18 | THE UNITED STATES OF AMERICA AS REPRESENTED BY VETERANS AFFAIRS, VETERANS AFFAIRS, U.S. GOVERNMENT AS REPRESENTED BY, |
| 9856286 | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | Apr 24, 14 | Jan 02, 18 | ABBVIE INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0368,214 | POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF | Aug 25, 22 | Nov 07, 24 | Not available |
| 2024/0199,683 | ANDROGEN RECEPTOR MODULATORS | Mar 14, 22 | Jun 20, 24 | Not available |
| 2024/0199,684 | PROCESS FOR THE PREPARATION OF DROSPIRENONE AS A FINE POWDER THROUGH A DOUBLE CHANGE OF CRYSTALLINE FORM | Apr 08, 22 | Jun 20, 24 | INDUSTRIALE CHIMICA S.R.L. |
| 2024/0101,592 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Nov 22, 21 | Mar 28, 24 | Not available |
| 2023/0295,220 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Dec 16, 22 | Sep 21, 23 | Not available |
| 2023/0061,432 | NEW TECHNOLOGY TO CONJUGATE THE TACCALONOLIDE MICROTUBULE STABILIZERS WITH LINKERS/PAYLOADS | Mar 06, 20 | Mar 02, 23 | Not available |
| 2022/0162,258 | Method for Obtaining Gamma-Oryzanol | Jul 29, 20 | May 26, 22 | Not available |
| 2022/0024,969 | METHOD FOR EXTRACTING ASTRAGALOSIDE IV FROM FRESH RADIX ASTRAGALI | Jul 20, 21 | Jan 27, 22 | Not available |
| 2021/0323,997 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Jun 09, 21 | Oct 21, 21 | Not available |
| 2021/0188,897 | NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF | Nov 16, 20 | Jun 24, 21 | Not available |
| 2021/0040,142 | C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF | Jul 20, 20 | Feb 11, 21 | Reata Pharmaceuticals, Inc. |
| 2018/0305,398 | C-3 NOVEL TRITERPENONE WITH C-28 UREA DERIVATIVES AS HIV INHIBITORS | Oct 12, 16 | Oct 25, 18 | Not available |
| 2018/0237,383 | NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE | Oct 24, 17 | Aug 23, 18 | Reata Pharmaceuticals, Inc. |
| 2018/0118,657 | METHODS FOR INHIBITING MUSCLE ATROPHY | Nov 06, 17 | May 03, 18 | The University of Iowa Research Foundation; The United States of America as represented by the Secretary of the Department of Veterans Affairs; |
| 2012/0128,733 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME | Jun 28, 11 | May 24, 12 | LABORATORIOS LEON FARMA SA |
| 2003/0083,493 | Eplerenone drug substance having high phase purity | Jul 09, 02 | May 01, 03 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
